Simplifying Global Compliance
FDA Needs to Share Trade Info, Shift Import Safety Burden to Industry: Official
Washington Drug Letter
ATHENS, Ga. — The FDA needs dramatic new powers from Congress, including the ability to share trade secrets and proprietary information with other regulators, to better police the drug industry’s supply chain, a top FDA official says.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing